Medical Care

Global Brain Ischemia Market Research Report 2024

Cerebral ischemia or brain ischemia, is a condition that occurs when there isn't enough blood flow to the brain to meet metabolic demand. This leads to limited oxygen supply or cerebral hypoxia and leads to the death of brain tissue, cerebral infarction, orischemic stroke.
The global Brain Ischemia market was valued at US$ 535.3 million in 2023 and is anticipated to reach US$ 712.8 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Brain Ischemia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Ischemia.
Report Scope
The Brain Ischemia market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Brain Ischemia market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Brain Ischemia companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer AG
H. Lundbeck
Bristol-Myers Squibb
Boehringer Ingelheim
ThromboGenics
Vernalis
Neurotec Pharma
Johnson and Johnson
Segment by Type
Anticoagulation Therapy
Antiplatelet
Other
Segment by Application
Hospital
Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Brain Ischemia companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Brain Ischemia Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Anticoagulation Therapy
1.2.3 Antiplatelet
1.2.4 Other
1.3 Market by Application
1.3.1 Global Brain Ischemia Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Brain Ischemia Market Perspective (2019-2030)
2.2 Brain Ischemia Growth Trends by Region
2.2.1 Global Brain Ischemia Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Brain Ischemia Historic Market Size by Region (2019-2024)
2.2.3 Brain Ischemia Forecasted Market Size by Region (2025-2030)
2.3 Brain Ischemia Market Dynamics
2.3.1 Brain Ischemia Industry Trends
2.3.2 Brain Ischemia Market Drivers
2.3.3 Brain Ischemia Market Challenges
2.3.4 Brain Ischemia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Brain Ischemia Players by Revenue
3.1.1 Global Top Brain Ischemia Players by Revenue (2019-2024)
3.1.2 Global Brain Ischemia Revenue Market Share by Players (2019-2024)
3.2 Global Brain Ischemia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Brain Ischemia Revenue
3.4 Global Brain Ischemia Market Concentration Ratio
3.4.1 Global Brain Ischemia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brain Ischemia Revenue in 2023
3.5 Brain Ischemia Key Players Head office and Area Served
3.6 Key Players Brain Ischemia Product Solution and Service
3.7 Date of Enter into Brain Ischemia Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Brain Ischemia Breakdown Data by Type
4.1 Global Brain Ischemia Historic Market Size by Type (2019-2024)
4.2 Global Brain Ischemia Forecasted Market Size by Type (2025-2030)
5 Brain Ischemia Breakdown Data by Application
5.1 Global Brain Ischemia Historic Market Size by Application (2019-2024)
5.2 Global Brain Ischemia Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Brain Ischemia Market Size (2019-2030)
6.2 North America Brain Ischemia Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Brain Ischemia Market Size by Country (2019-2024)
6.4 North America Brain Ischemia Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Brain Ischemia Market Size (2019-2030)
7.2 Europe Brain Ischemia Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Brain Ischemia Market Size by Country (2019-2024)
7.4 Europe Brain Ischemia Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Brain Ischemia Market Size (2019-2030)
8.2 Asia-Pacific Brain Ischemia Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Brain Ischemia Market Size by Region (2019-2024)
8.4 Asia-Pacific Brain Ischemia Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Brain Ischemia Market Size (2019-2030)
9.2 Latin America Brain Ischemia Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Brain Ischemia Market Size by Country (2019-2024)
9.4 Latin America Brain Ischemia Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Brain Ischemia Market Size (2019-2030)
10.2 Middle East & Africa Brain Ischemia Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Brain Ischemia Market Size by Country (2019-2024)
10.4 Middle East & Africa Brain Ischemia Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Detail
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Brain Ischemia Introduction
11.1.4 Bayer AG Revenue in Brain Ischemia Business (2019-2024)
11.1.5 Bayer AG Recent Development
11.2 H. Lundbeck
11.2.1 H. Lundbeck Company Detail
11.2.2 H. Lundbeck Business Overview
11.2.3 H. Lundbeck Brain Ischemia Introduction
11.2.4 H. Lundbeck Revenue in Brain Ischemia Business (2019-2024)
11.2.5 H. Lundbeck Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Brain Ischemia Introduction
11.3.4 Bristol-Myers Squibb Revenue in Brain Ischemia Business (2019-2024)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Detail
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Brain Ischemia Introduction
11.4.4 Boehringer Ingelheim Revenue in Brain Ischemia Business (2019-2024)
11.4.5 Boehringer Ingelheim Recent Development
11.5 ThromboGenics
11.5.1 ThromboGenics Company Detail
11.5.2 ThromboGenics Business Overview
11.5.3 ThromboGenics Brain Ischemia Introduction
11.5.4 ThromboGenics Revenue in Brain Ischemia Business (2019-2024)
11.5.5 ThromboGenics Recent Development
11.6 Vernalis
11.6.1 Vernalis Company Detail
11.6.2 Vernalis Business Overview
11.6.3 Vernalis Brain Ischemia Introduction
11.6.4 Vernalis Revenue in Brain Ischemia Business (2019-2024)
11.6.5 Vernalis Recent Development
11.7 Neurotec Pharma
11.7.1 Neurotec Pharma Company Detail
11.7.2 Neurotec Pharma Business Overview
11.7.3 Neurotec Pharma Brain Ischemia Introduction
11.7.4 Neurotec Pharma Revenue in Brain Ischemia Business (2019-2024)
11.7.5 Neurotec Pharma Recent Development
11.8 Johnson and Johnson
11.8.1 Johnson and Johnson Company Detail
11.8.2 Johnson and Johnson Business Overview
11.8.3 Johnson and Johnson Brain Ischemia Introduction
11.8.4 Johnson and Johnson Revenue in Brain Ischemia Business (2019-2024)
11.8.5 Johnson and Johnson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Brain Ischemia Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Anticoagulation Therapy
Table 3. Key Players of Antiplatelet
Table 4. Key Players of Other
Table 5. Global Brain Ischemia Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Brain Ischemia Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Brain Ischemia Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Brain Ischemia Market Share by Region (2019-2024)
Table 9. Global Brain Ischemia Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Brain Ischemia Market Share by Region (2025-2030)
Table 11. Brain Ischemia Market Trends
Table 12. Brain Ischemia Market Drivers
Table 13. Brain Ischemia Market Challenges
Table 14. Brain Ischemia Market Restraints
Table 15. Global Brain Ischemia Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Brain Ischemia Market Share by Players (2019-2024)
Table 17. Global Top Brain Ischemia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Ischemia as of 2023)
Table 18. Ranking of Global Top Brain Ischemia Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Brain Ischemia Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Brain Ischemia Product Solution and Service
Table 22. Date of Enter into Brain Ischemia Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Brain Ischemia Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Brain Ischemia Revenue Market Share by Type (2019-2024)
Table 26. Global Brain Ischemia Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Brain Ischemia Revenue Market Share by Type (2025-2030)
Table 28. Global Brain Ischemia Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Brain Ischemia Revenue Market Share by Application (2019-2024)
Table 30. Global Brain Ischemia Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Brain Ischemia Revenue Market Share by Application (2025-2030)
Table 32. North America Brain Ischemia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Brain Ischemia Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Brain Ischemia Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Brain Ischemia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Brain Ischemia Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Brain Ischemia Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Brain Ischemia Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Brain Ischemia Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Brain Ischemia Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Brain Ischemia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Brain Ischemia Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Brain Ischemia Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Brain Ischemia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Brain Ischemia Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Brain Ischemia Market Size by Country (2025-2030) & (US$ Million)
Table 47. Bayer AG Company Detail
Table 48. Bayer AG Business Overview
Table 49. Bayer AG Brain Ischemia Product
Table 50. Bayer AG Revenue in Brain Ischemia Business (2019-2024) & (US$ Million)
Table 51. Bayer AG Recent Development
Table 52. H. Lundbeck Company Detail
Table 53. H. Lundbeck Business Overview
Table 54. H. Lundbeck Brain Ischemia Product
Table 55. H. Lundbeck Revenue in Brain Ischemia Business (2019-2024) & (US$ Million)
Table 56. H. Lundbeck Recent Development
Table 57. Bristol-Myers Squibb Company Detail
Table 58. Bristol-Myers Squibb Business Overview
Table 59. Bristol-Myers Squibb Brain Ischemia Product
Table 60. Bristol-Myers Squibb Revenue in Brain Ischemia Business (2019-2024) & (US$ Million)
Table 61. Bristol-Myers Squibb Recent Development
Table 62. Boehringer Ingelheim Company Detail
Table 63. Boehringer Ingelheim Business Overview
Table 64. Boehringer Ingelheim Brain Ischemia Product
Table 65. Boehringer Ingelheim Revenue in Brain Ischemia Business (2019-2024) & (US$ Million)
Table 66. Boehringer Ingelheim Recent Development
Table 67. ThromboGenics Company Detail
Table 68. ThromboGenics Business Overview
Table 69. ThromboGenics Brain Ischemia Product
Table 70. ThromboGenics Revenue in Brain Ischemia Business (2019-2024) & (US$ Million)
Table 71. ThromboGenics Recent Development
Table 72. Vernalis Company Detail
Table 73. Vernalis Business Overview
Table 74. Vernalis Brain Ischemia Product
Table 75. Vernalis Revenue in Brain Ischemia Business (2019-2024) & (US$ Million)
Table 76. Vernalis Recent Development
Table 77. Neurotec Pharma Company Detail
Table 78. Neurotec Pharma Business Overview
Table 79. Neurotec Pharma Brain Ischemia Product
Table 80. Neurotec Pharma Revenue in Brain Ischemia Business (2019-2024) & (US$ Million)
Table 81. Neurotec Pharma Recent Development
Table 82. Johnson and Johnson Company Detail
Table 83. Johnson and Johnson Business Overview
Table 84. Johnson and Johnson Brain Ischemia Product
Table 85. Johnson and Johnson Revenue in Brain Ischemia Business (2019-2024) & (US$ Million)
Table 86. Johnson and Johnson Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Brain Ischemia Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Brain Ischemia Market Share by Type: 2023 VS 2030
Figure 3. Anticoagulation Therapy Features
Figure 4. Antiplatelet Features
Figure 5. Other Features
Figure 6. Global Brain Ischemia Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Brain Ischemia Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Clinics Case Studies
Figure 10. Other Case Studies
Figure 11. Brain Ischemia Report Years Considered
Figure 12. Global Brain Ischemia Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Brain Ischemia Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Brain Ischemia Market Share by Region: 2023 VS 2030
Figure 15. Global Brain Ischemia Market Share by Players in 2023
Figure 16. Global Top Brain Ischemia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Ischemia as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Brain Ischemia Revenue in 2023
Figure 18. North America Brain Ischemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Brain Ischemia Market Share by Country (2019-2030)
Figure 20. United States Brain Ischemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Brain Ischemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Brain Ischemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Brain Ischemia Market Share by Country (2019-2030)
Figure 24. Germany Brain Ischemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Brain Ischemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Brain Ischemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Brain Ischemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Brain Ischemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Brain Ischemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Brain Ischemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Brain Ischemia Market Share by Region (2019-2030)
Figure 32. China Brain Ischemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Brain Ischemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Brain Ischemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Brain Ischemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Brain Ischemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Brain Ischemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Brain Ischemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Brain Ischemia Market Share by Country (2019-2030)
Figure 40. Mexico Brain Ischemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Brain Ischemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Brain Ischemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Brain Ischemia Market Share by Country (2019-2030)
Figure 44. Turkey Brain Ischemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Brain Ischemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Bayer AG Revenue Growth Rate in Brain Ischemia Business (2019-2024)
Figure 47. H. Lundbeck Revenue Growth Rate in Brain Ischemia Business (2019-2024)
Figure 48. Bristol-Myers Squibb Revenue Growth Rate in Brain Ischemia Business (2019-2024)
Figure 49. Boehringer Ingelheim Revenue Growth Rate in Brain Ischemia Business (2019-2024)
Figure 50. ThromboGenics Revenue Growth Rate in Brain Ischemia Business (2019-2024)
Figure 51. Vernalis Revenue Growth Rate in Brain Ischemia Business (2019-2024)
Figure 52. Neurotec Pharma Revenue Growth Rate in Brain Ischemia Business (2019-2024)
Figure 53. Johnson and Johnson Revenue Growth Rate in Brain Ischemia Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies